Brief: INmune Bio Announces $9.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
25/04/2024 14:38
April 25 (Reuters) - INmune Bio Inc INMB.O :
* INMUNE BIO INC. ANNOUNCES $9.7 MILLION REGISTERED DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX2G6152
Further company coverage: INMB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview